Susceptibility of W/WV mice to murine cytomegalovirus infection. 1988

T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
Department of Microbiology, Miyazaki Medical College, Japan.

The susceptibility of congenitally anemic W/WV mice to infection with murine cytomegalovirus (MCMV) was examined. W/WV mice showed a higher mortality rate and shorter survival time after MCMV infection than did their +/+ littermate mice. In addition, W/WV mice showed a lower plaque-forming unit (PFU) per 50% lethal dose (LD50) and produced higher titers of infectious virus in various organs. The mortality rate and survival time of W/WV mice which received a bone marrow graft 4 weeks before infection was completely restored to the level for +/+ mice, suggesting the importance of the cells of myeloid origin. Although natural killer (NK) activity of W/WV mice was comparable to that of +/+ mice before infection, marked reduction was observed after MCMV infection. Furthermore, OK-432 treatment failed to enhance NK activity of W/WV mice. Impaired NK response was also completely restored by bone marrow grafting 4 weeks before infection. The level of serum interferon (IFN) of infected or uninfected W/WV mice was comparable to that of +/+ mice. Therefore, impaired NK inducibility seems to be responsible, at least in part, for the high susceptibility of W/WV mice to MCMV infection.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D010844 Picibanil A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity. NSC-B116209,OK-432,Picibanyl,Streptococcal OK-432,Streptococcal Preparation OK-432,NSC B116209,NSCB116209,OK 432,OK432,Streptococcal OK 432,Streptococcal OK432,Streptococcal Preparation OK 432,Streptococcal Preparation OK432
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
October 1991, Immunology and cell biology,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
May 1998, Cellular and molecular life sciences : CMLS,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
February 1991, Infection and immunity,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
June 1976, The Journal of laboratory and clinical medicine,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
February 2004, Immunology letters,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
January 2017, Frontiers in immunology,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
November 1985, Thrombosis research,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
July 1978, Journal of cellular physiology,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
December 1973, Blood,
T Ohashi, and Y Nawa, and Y Minamishima, and M Owhashi
November 2001, Burns : journal of the International Society for Burn Injuries,
Copied contents to your clipboard!